April 9, 2019

New research suggests women with ovarian cancer are not undergoing genetic testing, despite existing clinical practice guidelines that recommend nearly all women with ovarian cancer receive genetic testing.

March 1, 2019

Developing and validating predictive markers for treatment outcomes and then confirming how those markers can be used to help patients and clinicians choose appropriate therapies is often a long step-wise process. New research presented at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium points to multiple potential approaches for determining which patients are most likely to benefit from immunotherapy.